Description

Simple

Clinical

Overview

Pharmacology

Indication

Information currently not available.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Gentamicin C1a
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
(R)-warfarin
The risk or severity of bleeding can be increased when Gentamicin C1a is combined with (R)-warfarin.
(S)-Warfarin
The risk or severity of bleeding can be increased when Gentamicin C1a is combined with (S)-Warfarin.
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Gentamicin C1a is combined with 4-hydroxycoumarin.
Abacavir
Gentamicin C1a may decrease the excretion rate of Abacavir which could result in a higher serum level.
Acarbose
Gentamicin C1a may decrease the excretion rate of Acarbose which could result in a higher serum level.
Aceclofenac
The risk or severity of nephrotoxicity can be increased when Aceclofenac is combined with Gentamicin C1a.
Acemetacin
The risk or severity of nephrotoxicity can be increased when Acemetacin is combined with Gentamicin C1a.
Acenocoumarol
The risk or severity of bleeding can be increased when Gentamicin C1a is combined with Acenocoumarol.
Acetaminophen
Gentamicin C1a may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
Acetylcholine
The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Gentamicin C1a.
Acetyldigitoxin
The risk or severity of adverse effects can be increased when Gentamicin C1a is combined with Acetyldigitoxin.
Acetyldigoxin
The risk or severity of adverse effects can be increased when Gentamicin C1a is combined with Acetyldigoxin.
Acetylsalicylic acid
The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Gentamicin C1a.
Aclidinium
Gentamicin C1a may decrease the excretion rate of Aclidinium which could result in a higher serum level.
Acrivastine
Gentamicin C1a may decrease the excretion rate of Acrivastine which could result in a higher serum level.
Acyclovir
Gentamicin C1a may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Adefovir
The risk or severity of nephrotoxicity can be increased when Gentamicin C1a is combined with Adefovir.
Adefovir dipivoxil
The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Gentamicin C1a.
Albutrepenonacog alfa
Gentamicin C1a may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
Alclofenac
The risk or severity of nephrotoxicity can be increased when Alclofenac is combined with Gentamicin C1a.